Salta al contenuto principale
Home

Dedicated to discovery

  • A proposito di ELGA
    • A proposito di ELGA
    • Carriere
    • Eventi
  • Supporto
    • Laboratory Planning
  • Contatti
  • EN
  • DE
  • ES
  • FR
  • PT
  • EN-US
Home
  • Prodotti
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY® 30
    • ELGA Gamma Completa di Prodotti
  • Applicazioni
    • Analisi microbiologica
    • Biochimica clinica
    • Colture cellulari
    • Cromatografia liquida
      • High Performance Liquid Chromatography
    • Elettrochimica
    • Gascromatografia
    • Genetica
    • High Performance Liquid Chromatography (HPLC)
    • Immunochimica
    • Requisiti dell'acqua per laboratori generici
    • Spettrofotometria
    • Spettrometria di massa
    • Spettroscopia atomica
  • Tecnologie
    • Activated Carbon
    • Electrodeionization (EDI)
    • Filtration
    • Ion Exchange
    • PureSure
    • Reverse Osmosis
    • Ultraviolet
  • Impurità nell'acqua
    • Dissolved Gases
    • Inorganic Compounds
    • Microorganisms & Bacteria
    • Organic Compounds
    • Particulates
  • Conoscenza
    • BROSCHÜREN
    • Blog
    • Casi di studio
    • Acqua ultrapura
    • Guide e libri bianchi
  • Where to buy
  • Contattaci
Home
  • Contattaci
  • Prodotti
    • PURELAB
      • PURELAB® Dispenser
      • PURELAB® Flex
      • PURELAB® Quest
      • PURELAB® Pharma Compliance
      • PURELAB® Chorus 1 Complete
      • PURELAB® Chorus 1
      • PURELAB® Chorus 2
      • PURELAB® Chorus 3
      • PURELAB® Chorus 2 +
    • CENTRA
      • CENTRA® R60/120
      • CENTRA® R200
      • CENTRA® RDS
    • MEDICA
      • MEDICA® 150
      • MEDICA® 7/15
      • MEDICA® BIOX 2024
      • MEDICA® Pro-R & Pro-RE
      • MEDICA® R200
      • MEDICA® EDI 15/30
      • MEDICA® Pro-LPS
      • MEDICA® Pro EDI 60/120
      • MEDICA® BIOX
      • Hubgrade
    • BIOPURE
      • BIOPURE® 300/600
    • PURENERGY® 30
    • ELGA Gamma Completa di Prodotti
  • Applicazioni
    • Analisi microbiologica
    • Biochimica clinica
    • Colture cellulari
    • Cromatografia liquida
      • High Performance Liquid Chromatography
    • Elettrochimica
    • Gascromatografia
    • Genetica
    • High Performance Liquid Chromatography (HPLC)
    • Immunochimica
    • Requisiti dell'acqua per laboratori generici
    • Spettrofotometria
    • Spettrometria di massa
    • Spettroscopia atomica
  • Tecnologie
    • Activated Carbon
    • Electrodeionization (EDI)
    • Filtration
    • Ion Exchange
    • PureSure
    • Reverse Osmosis
    • Ultraviolet
  • Impurità nell'acqua
    • Dissolved Gases
    • Inorganic Compounds
    • Microorganisms & Bacteria
    • Organic Compounds
    • Particulates
  • Conoscenza
    • BROSCHÜREN
    • Blog
    • Casi di studio
    • Acqua ultrapura
    • Guide e libri bianchi
  • Where to buy
  • Contattaci
  • A proposito di ELGA
    • A proposito di ELGA
    • Carriere
    • Eventi
  • Supporto
    • Laboratory Planning
  • Contatti
  • EN
  • DE
  • ES
  • FR
  • PT
  • EN-US
  • Normativa sulla privacy
  • Termini e condizioni
  • Dichiarazioni di conformità legale globale
  • Brevetti
  • Trademarks
  • Impressum
  • A Step Towards a Non–Invasive Test for Monitoring Patients with Heart Failure
Analytical Chemistry
Science of the Future

A Step Towards a Non–Invasive Test for Monitoring Patients with Heart Failure

24 Ago 2020
- by Dr Alison Halliday

Close up of doctor with sample of saliva from sick womanResearchers demonstrate the potential of using saliva analysis to predict flare-ups in people with heart failure, which could help them to live longer and better lives. 

At least 26 million people worldwide are currently living with heart failure – and these numbers are expected to increase dramatically in the future. 

When a person first develops heart failure, their body will undergo several physiological changes to try and compensate. But eventually, their body can no longer keep up and they start to experience symptoms such as shortness of breath and fatigue. Their condition will progressively worsen over time – and around four in ten patients will not survive for more than five years after their diagnosis.

A person living with heart failure may experience acute heart failure, which will often require hospital admission. If doctors could reliably predict an imminent flare-up, it may be possible to prevent it from happening – improving the quality of life for people living with heart failure and potentially lengthening their lives.

A Non–Invasive Test

In a new study, published in Scientific Reports, researchers carry out a pilot study to investigate the feasibility of monitoring patients with heart failure by testing their saliva.1

The researchers developed a new method to simultaneously measure the concentration of two potential biomarkers – 8–isoPGF2α and cortisol – in saliva. This involved combining microextraction by packed sorbent (MEPS) with ultra–high–performance liquid chromatography coupled to electrospray ionization triple–quadrupole mass spectrometry (UHPLC–ESI–MS/MS).

They demonstrated that this approach provided satisfactory recovery (95–110%) and an adequate detection limit (10pg/ml) in saliva samples. 

Monitoring Patients with Heart Failure

The team then carried out a pilot study on saliva samples from 44 patients with heart failure who were hospitalized due to a flare-up. They used validated procedures to monitor a panel of candidate biomarkers for heart failure – lactate, uric acid, TNF–α, cortisol, α–amylase and 8–isoPGF2α – collected at regular times during their stay.

They measured the concentration of TNF–α with an enzyme-linked immunosorbent assay (ELISA) using ultrapure water obtained from an ELGA PURELAB® laboratory water purification system, minimising the risk of introducing contaminants that may affect their results.

Their results identified that about 70% of patients showed at least a 3–fold decrease of two biomarkers – 8–isoPGF2α and lactate – in their saliva at the point of discharge from hospital, which is likely related to an improvement in clinical symptoms due to treatment. Assuming that high salivary concentrations of these two chemicals build up progressively over time in saliva, their monitoring may provide an early warning of acute heart failure.

Preventing Flare-Ups

This study identifies 8–isoPGF2α and lactate as possible non–invasive biomarkers for heart failure monitoring – and that saliva analysis has potential applications in clinical practice. 

If these biomarkers are validated in future studies, it could pave the way towards the development of new sensing devices that could be used at home to help prevent flare-ups in patients with heart failure – improving and possibly prolonging their lives. 

Why choose ELGA LabWater?

ELGA LabWater has been a trusted name in pure and ultrapure water since 1937. We believe in giving you choice in how you use our water purification solutions, supported by excellent service and support.
 

Reference:

1. Ghimenti S., et al. Salivary lactate and 8–isoprostaglandin F2α as potential non–invasive biomarkers for monitoring heart failure: a pilot study. Sci Rep (2020):10;7441. https://doi.org/10.1038/s41598-020-64112-2

 

Dr Alison Halliday

After completing an undergraduate degree in Biochemistry & Genetics at Sheffield University, Alison was awarded a PhD in Human Molecular Genetics at the University of Newcastle. She carried out five years as a Senior Postdoctoral Research Fellow at UCL, investigating the genes involved in childhood obesity syndrome. Moving into science communications, she spent ten years at Cancer Research UK engaging the public about the charity’s work. She now specialises in writing about research across the life sciences, medicine and health.

  • Sales Enquiry
  • Richiedi un Preventivo
  • Technical Support
  • Trova un Partner Approvato

Sales Enquiry

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

I'd like to receive updates from ELGA LabWater & ELGA Approved Partners based on my details.

Richiedi un Preventivo

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

I'd like to receive updates from ELGA LabWater & ELGA Approved Partners based on my details.

Technical Support

At ELGA LabWater, we have exciting offers and news about our products and services that we hope you’d like to hear about. We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details in our Privacy Policy.

ELGA LabWater works with a network of Approved Partners. In order to answer your questions or enquiries, we may pass your contact details to an Approved Partner, who may contact you directly. 

Call us

Can't find what you are looking for?

Support Number
+44 (0)20 3567 7300
United Kingdom Sales
+44 (0)1628 879 704
United States of America Sales
+1 877-315-3542
France Sales
+33 1 40 83 65 00
China Sales
+86 400-616-8882

 

ELGA LabWater Sede Centrale

Lane End Business Park
Lane End, High Wycombe
HP14 3BY
United Kingdom
T: +44 (0) 203 567 7300
F: +44 (0) 203 567 7205

Casi di Studio

  • Abbott Diagnostics
  • DASA Diagnostica Medica
  • NeoDIN Istituto Medico
  • North Staffordshire NHS Trust
  • Scuola Professionale Olsberg

Risorse

  • Informazioni sull'acqua ultrapura
  • Guide e libri bianchi
  • Tecnologie per la purificazione dell'acqua
  • Applicazioni di laboratorio
  • Impurità nell'acqua
  • Latest Blog
  • Water Purity - Different Types of Pure Water
  • What is Clinical Laboratory Reagent Water (CLSI)?
  • What is Total Organic Carbon (TOC)?

© VWS (UK) Ltd. che opera come ELGA LabWater. 2025 - Tutti i diritti riservati.
ELGA è il marchio mondiale dell'acqua di laboratorio di Veolia.

  • Normativa sulla privacy
  • Termini e condizioni
  • Dichiarazioni di conformità legale globale
  • Brevetti
  • Trademarks
  • Impressum
  • Lingua
    • Deutsch
    • English
    • Español
    • Français
    • Italiano
    • Português
    • 日本語
    • 中文
  • Altri Siti Veolia
    • Veolia
    • Veolia Foundation
    • Veolia Water Technologies
Elga Veolia
TOP

© 2017 ELGA Veolia